DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Rating of “Hold” from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has earned an average rating of “Hold” from the fourteen analysts that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $13.5455.

XRAY has been the subject of a number of recent analyst reports. Citigroup initiated coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, April 15th. They set a “sell” rating and a $10.00 price target for the company. Barrington Research boosted their price objective on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the company an “outperform” rating in a research report on Monday, March 2nd. Barclays reduced their price target on shares of DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating for the company in a report on Thursday, June 4th. Wells Fargo & Company boosted their price target on shares of DENTSPLY SIRONA from $12.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Finally, Weiss Ratings lowered shares of DENTSPLY SIRONA from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 6th.

DENTSPLY SIRONA Stock Performance

XRAY opened at $10.33 on Friday. The stock has a market capitalization of $2.07 billion, a price-to-earnings ratio of -3.28, a PEG ratio of 1.19 and a beta of 0.89. The company has a fifty day moving average of $10.87 and a 200 day moving average of $11.69. DENTSPLY SIRONA has a fifty-two week low of $9.40 and a fifty-two week high of $17.09. The company has a debt-to-equity ratio of 1.52, a quick ratio of 0.98 and a current ratio of 1.53.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Tuesday, May 5th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.28 by ($0.01). DENTSPLY SIRONA had a negative net margin of 17.06% and a positive return on equity of 18.83%. The company had revenue of $880.00 million for the quarter, compared to analysts’ expectations of $841.80 million. During the same period in the previous year, the business posted $0.43 earnings per share. The business’s revenue was up .1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, sell-side analysts forecast that DENTSPLY SIRONA will post 1.42 earnings per share for the current fiscal year.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Brian P. Mckeon purchased 10,000 shares of the business’s stock in a transaction on Friday, June 12th. The shares were acquired at an average price of $10.12 per share, for a total transaction of $101,200.00. Following the purchase, the director owned 10,000 shares of the company’s stock, valued at $101,200. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Michael J. Barber purchased 15,175 shares of the business’s stock in a transaction on Thursday, June 11th. The shares were bought at an average price of $9.88 per share, for a total transaction of $149,929.00. Following the purchase, the director directly owned 55,943 shares in the company, valued at $552,716.84. This represents a 37.22% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders have purchased 35,160 shares of company stock worth $351,179. 0.46% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at $26,000. Eurizon Capital SGR S.p.A. acquired a new position in DENTSPLY SIRONA during the fourth quarter worth $26,000. Caitong International Asset Management Co. Ltd raised its position in DENTSPLY SIRONA by 337.9% during the third quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 2,122 shares during the period. Huntington National Bank raised its position in DENTSPLY SIRONA by 292.9% during the third quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 2,077 shares during the period. Finally, Farther Finance Advisors LLC raised its position in DENTSPLY SIRONA by 119.1% during the fourth quarter. Farther Finance Advisors LLC now owns 3,773 shares of the medical instruments supplier’s stock worth $43,000 after acquiring an additional 2,051 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.